Nuredis, Inc.
1455 Adams Drive
Suite 1120
Menlo Park
California
94025
United States
Website: http://nuredis.com/
Email: info@nuredis.com
About Nuredis, Inc.
Nuredis, a pre-clinical stage company, is developing small molecule therapies to treat a group of inherited neurodegenerative and neuromuscular diseases caused by the expansion of normally-short nucleotide repeats sequences in human genes, with Huntington's Disease as the first indication.
YEAR FOUNDED:
2016
LEADERSHIP:
Founder: Stanley N. Cohen
CEO: Julie Anne Smith
1 article about Nuredis, Inc.
-
Biotech Movers and Shakers Aug. 27
8/27/2018
Who made a splash in the biotech world this week? Here are some notable people.